Formula milk is derived from cow's milk and contains cow's milk proteins that a small but significant proportion of infants cannot tolerate. Cow's milk protein allergy (CMPA) is frequently over-diagnosed (colic and normal infant regurgitation are often attributed to it) and sometimes under-diagnosed (non-IgE-mediated forms are subtle and can be missed). Understanding the evidence helps parents and clinicians make better-informed decisions.
Healthbooq covers infant feeding and health in the first year.
Understanding CMPA
Cow's milk protein allergy occurs when the immune system mounts a response to the proteins in cow's milk, primarily casein and whey proteins. There are two main immunological mechanisms:
IgE-mediated (immediate) reactions involve antibodies of the IgE class and produce symptoms within minutes to 2 hours of exposure. Symptoms include urticaria (hives), lip/tongue swelling, vomiting, and in severe cases, anaphylaxis. This is the classic allergic pattern.
Non-IgE-mediated (delayed) reactions are cell-mediated and produce symptoms over hours to days. They are more common in infants than IgE-mediated reactions and have a more subtle presentation: persistent vomiting, faltering growth, blood in stool, severe eczema, and symptoms resembling colic. Because these symptoms are non-specific and shared by many other conditions, diagnosis is more difficult.
Around 2-3% of formula-fed infants have CMPA, according to population studies. The rate in exclusively breastfed infants is substantially lower because the protein is partially digested by the mother before reaching the baby.
Recognising CMPA in a Formula-Fed Baby
IgE-mediated CMPA: the infant has a clear reaction within minutes to a couple of hours of a feed. The reaction may include visible urticaria, significant vomiting, swollen lips or tongue, or respiratory symptoms. These are clear and alarming.
Non-IgE-mediated CMPA is more commonly the diagnostic challenge. Symptoms include: persistent and excessive vomiting beyond normal posseting; significant eczema starting in infancy and not responding to topical treatments; blood and/or mucus in the stool; faltering growth (poor weight gain); and extreme unsettledness that does not respond to the measures that usually settle normal infant colic.
What Is Not CMPA
Normal posseting (spitting up small amounts after feeds), mild wind and fussiness, and normal infant crying are not symptoms of CMPA. There is substantial evidence that CMPA is over-diagnosed in infants, partly because parents are understandably keen to find an explanation for normal but distressing infant behaviour, and partly because switching to a hypoallergenic formula and noticing improvement is subject to the natural resolution of symptoms over time.
Research by Adam Fox at King's College London and the UK iMAP guideline group has been influential in developing more structured diagnostic criteria to reduce over-diagnosis.
Diagnosis
Non-IgE-mediated CMPA cannot be confirmed by blood tests or skin prick testing, because IgE is not involved. Diagnosis is clinical, based on a trial of elimination: replacing standard formula with an extensively hydrolysed formula (eHF) for 2-4 weeks and assessing whether symptoms improve. If symptoms resolve on eHF and return when cow's milk protein is reintroduced, the diagnosis is confirmed.
For IgE-mediated CMPA, skin prick testing and specific IgE blood tests are helpful but are not perfect: a positive result indicates sensitisation, which must be interpreted alongside the clinical history.
Treatment
Extensively hydrolysed formula (eHF): the proteins are broken down into smaller peptides that do not trigger an immune response in most (but not all) children with CMPA. This is first-line for non-IgE-mediated and most IgE-mediated CMPA. Examples include Aptamil Pepti and Nutramigen.
Amino acid formula (AAF): for infants who do not respond to eHF, or those with severe IgE-mediated reactions or eosinophilic oesophagitis. Proteins are fully broken down to individual amino acids. Examples include Neocate and Alfamino.
Soy formula is not recommended as first-line in the UK for infants under 6 months because approximately 10-15% of infants with CMPA also react to soy protein, and there are theoretical concerns about phytoestrogens.
Prognosis
Most children with CMPA outgrow it. Studies show that approximately 50% are tolerant by 1 year, 70-80% by 2-3 years, and over 90% by 5 years. A structured milk ladder protocol (progressively introducing baked, then non-baked milk in different forms) is used to reintroduce cow's milk proteins under GP or allergy clinic supervision.
Key Takeaways
Cow's milk protein allergy (CMPA) is the most common food allergy in infancy, affecting 2-3% of formula-fed infants. It can present as an immediate IgE-mediated reaction (urticaria, vomiting within minutes) or as a delayed non-IgE-mediated reaction (eczema, blood in stool, persistent vomiting, colic-like symptoms) developing over hours to days. Diagnosis relies on clinical history and response to elimination; skin prick testing and IgE blood tests are less useful for non-IgE-mediated CMPA. Management involves switching to an extensively hydrolysed formula or, for severe cases, an amino acid formula. Most infants outgrow CMPA by 3-5 years.
